Olanzapine and OFC improve HR-QoL in depressed bipolar patients

A secondary quality-of-life analysis in an 8-week trial in bipolar I patients suggested significantly superior effects of olanzapine and OFC on quality of life in bipolar depressed patients compared with placebo.

GSK counterclaim: